Your browser doesn't support javascript.
loading
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
Fisher, George A; Wolin, Edward M; Liyanage, Nilani; Pitman Lowenthal, Susan; Mirakhur, Beloo; Pommier, Rodney F; Shaheen, Montaser; Vinik, Aaron.
Afiliação
  • Fisher GA; Stanford University School of Medicine, Stanford, California, USA georgeaf@stanford.edu.
  • Wolin EM; Montefiore Einstein Center for Cancer Care, Bronx, New York, USA.
  • Liyanage N; Ipsen, Les Ulis, France.
  • Pitman Lowenthal S; Ipsen Biopharmaceuticals, Basking Ridge, New Jersey, USA.
  • Mirakhur B; Ipsen Biopharmaceuticals, Basking Ridge, New Jersey, USA.
  • Pommier RF; Oregon Health and Science University, Portland, Oregon, USA.
  • Shaheen M; University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.
  • Vinik A; Eastern Virginia Medical School, Norfolk, Virginia, USA.
Oncologist ; 23(1): 16-24, 2018 01.
Article em En | MEDLINE | ID: mdl-29038234

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Somatostatina / Tumores Neuroendócrinos / Diarreia / Rubor / Géis / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Somatostatina / Tumores Neuroendócrinos / Diarreia / Rubor / Géis / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos